Bolt Biotherapeutics, Inc. (BOLT)

Bolt Biotherapeutics Statistics

Total Valuation

BOLT has a market cap or net worth of $12.06 million. The enterprise value is -$2.07 million.

Market Cap	12.06M
Enterprise Value	-2.07M

Important Dates

The last earnings date was Monday, May 12, 2025, after market close.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

BOLT has 38.34 million shares outstanding. The number of shares has increased by 0.91% in one year.

Current Share Class	38.34M
Shares Outstanding	38.34M
Shares Change (YoY)	+0.91%
Shares Change (QoQ)	+0.14%
Owned by Insiders (%)	0.63%
Owned by Institutions (%)	23.47%
Float	28.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.31
Forward PS	10.82
PB Ratio	0.26
P/TBV Ratio	0.26
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.13, with a Debt / Equity ratio of 0.53.

Current Ratio	3.13
Quick Ratio	2.92
Debt / Equity	0.53
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -83.92% and return on invested capital (ROIC) is -40.50%.

Return on Equity (ROE)	-83.92%
Return on Assets (ROA)	-34.57%
Return on Invested Capital (ROIC)	-40.50%
Return on Capital Employed (ROCE)	-87.50%
Revenue Per Employee	$69,962
Profits Per Employee	-$1.22M
Employee Count	52
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -58.61% in the last 52 weeks. The beta is 0.96, so BOLT's price volatility has been similar to the market average.

Beta (5Y)	0.96
52-Week Price Change	-58.61%
50-Day Moving Average	0.36
200-Day Moving Average	0.52
Relative Strength Index (RSI)	42.79
Average Volume (20 Days)	734,383

Short Selling Information

The latest short interest is 256,527, so 0.67% of the outstanding shares have been sold short.

Short Interest	256,527
Short Previous Month	264,862
Short % of Shares Out	0.67%
Short % of Float	0.89%
Short Ratio (days to cover)	2.09

Income Statement

In the last 12 months, BOLT had revenue of $3.64 million and -$63.35 million in losses. Loss per share was -$1.66.

Revenue	3.64M
Gross Profit	-47.48M
Operating Income	-63.26M
Pretax Income	-63.03M
Net Income	-63.35M
EBITDA	-61.54M
EBIT	-63.26M
Loss Per Share	-$1.66

Balance Sheet

The company has $38.84 million in cash and $24.71 million in debt, giving a net cash position of $14.13 million or $0.37 per share.

Cash & Cash Equivalents	38.84M
Total Debt	24.71M
Net Cash	14.13M
Net Cash Per Share	$0.37
Equity (Book Value)	46.81M
Book Value Per Share	1.22
Working Capital	28.95M

Cash Flow

In the last 12 months, operating cash flow was -$57.90 million and capital expenditures -$41,000, giving a free cash flow of -$57.94 million.

Operating Cash Flow	-57.90M
Capital Expenditures	-41,000
Free Cash Flow	-57.94M
FCF Per Share	-$1.51

Margins

Gross Margin	n/a
Operating Margin	-1,738.84%
Pretax Margin	-1,741.26%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BOLT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.91%
Shareholder Yield	-0.91%
Earnings Yield	-525.19%
FCF Yield	-480.40%

Analyst Forecast

The average price target for BOLT is $2.50, which is 694.66% higher than the current price. The consensus rating is "Buy".

Price Target	$2.50
Price Target Difference	694.66%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	27.09%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BOLT has an Altman Z-Score of -8.73 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.73
Piotroski F-Score	1